Induction of specific CD8+ T cells against intracellular bacteria by CD8+ T-cell-oriented immunization approaches

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Nagata, Toshi ^a   Koide, Yukio ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VECTOR; BCG VACCINE; DNA VACCINE; NAKED DNA;

ACTIVE IMMUNIZATION; ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; BACTERIAL INFECTION; BCG VACCINATION; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DENDRITIC CELL; DNA IMMUNIZATION; HUMAN; HUMORAL IMMUNITY; INTRACELLULAR BACTERIUM; LISTERIA; LISTERIA MONOCYTOGENES; LISTERIOSIS; MICROBIAL ATTENUATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; REVIEW; SALMONELLA; SHIGELLA; T LYMPHOCYTE ACTIVATION; TOTAL QUALITY MANAGEMENT; TUBERCULOSIS; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ANIMALIA; BACTERIA (MICROORGANISMS); LENTIVIRUS; LISTERIA; LISTERIA MONOCYTOGENES; MYCOBACTERIUM TUBERCULOSIS; SALMONELLA; SHIGELLA;

EID: 77953506240     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/764542     Document Type: Review

References (90)

1. Hess J., Schaible U., Raupach B., Kaufmann S. H. E., Exploiting the immune system: toward new vaccines against intracellular bacteria Advances in Immunology 2000 75 1 88
2. Kaufmann S. H. E., Paul W. E., Immunity to intracellular bacteria Fundamental Immunity 2003 5th Philadelphia, Pa, USA Lippincott Williams Wilkins 1229 1261
3. Bleackley R. C., Paul W. E., Cytotoxic T lymphocytes Fundamental Immunology 2008 6th Philadelphia, Pa, USA Lippincott Williams Wikins 1079 1095
4. Russell D. G., Cossart P., Boquet P., Normark S., Rappuoli R., Where to stay inside the cell: a homesteader's guide to intracellular parasitism Cellular Microbiology 2005 2nd Washington, DC, USA ASM Press 227 253
5. Cossart P., Mengaud J., Listeria monocytogenes. A model system for the molecular study of intracellular parasitism Molecular Biology and Medicine 1989 6 463 474
6. Delamarre L., Mellman I., Paul W. E., Cell biology of antigen processing and presentation Fundamental Immunology 2008 6th Philadelphia, Pa, USA Lippincott Williams Wilkins 614 630
7. Pamer E., Cresswell P., Mechanisms of MHC class I-restricted antigen processing Annual Review of Immunology 1998 16 323 358
8. Winau F., Kaufmann S. H. E., Schaible U. E., Apoptosis paves the detour path for CD8 T cell activation against intracellular bacteria Cellular Microbiology 2004 6 7 599 607
9. Winau F., Weber S., Sad S., Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis Immunity 2006 24 1 105 117
10. Andersen P., Doherty T. M., The success and failure of BCGimplications for a novel tuberculosis vaccine Nature Reviews Microbiology 2005 3 8 656 662
11. Bloom B. R., Fine P. E. M., Bloom B. R., The BCG experience: implications for future vaccines against tuberculosis Tuberculosis: Pathogenesis, Protection, and Control 1994 Washington, DC, USA ASM Press 531 557
12. Fine P. E. M., Variation in protection by BCG: implications of and for heterologous immunity Lancet 1995 346 8986 1339 1345
13. Sterne J. A. C., Rodrigues L. C., Guedes I. N., Does the efficacy of BCG decline with time since vaccination? International Journal of Tuberculosis and Lung Disease 1998 2 3 200 207
14. Kaufmann S. H. E., Baumann S., Eddine A. N., Exploiting immunology and molecular genetics for rational vaccine design against tuberculosis International Journal of Tuberculosis and Lung Disease 2006 10 10 1068 1079
15. Flynn J. L., Goldstein M. M., Triebold K. J., Koller B., Bloom B. R., Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection Proceedings of the National Academy of Sciences of the United States of America 1992 89 24 12013 12017
16. Ladel C. H., Daugelat S., Kaufmann S. H. E., Immune response to Mycobacterium bovis bacille CalmetteGurin infection in major histocompatibility complex class I- and II deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance European Journal of Immunology 1995 25 2 377 384
17. Hess J., Miko D., Catic A., Lehmensiek V., Russell D. G., Kaufmann S. H. E., Mycobacterium bovis bacille CalmetteGurin strains secreting listeriolysin of Listeria monocytogenes Proceedings of the National Academy of Sciences of the United States of America 1998 95 9 5299 5304
18. Grode L., Seiler P., Baumann S., Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille CalmetteGurin mutants that secrete listeriolysin The Journal of Clinical Investigation 2005 115 9 2472 2479
19. Horwitz M. A., Harth G., Dillon B. J., Maslea-Gali S., Recombinant bacillus CalmetteGurin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity againts tuberculosis than conventional BCG vaccines in a highly susceptible animal model Proceedings of the National Academy of Sciences of the United States of America 2000 97 25 13853 13858
20. Wang Q.-l., Pan Q., Ma Y., An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis Vaccine 2009 27 48 6712 6722
21. Raz E., Carson D. A., Parker S. E., Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses Proceedings of the National Academy of Sciences of the United States of America 1994 91 20 9519 9523
22. Fan H., Lin Q., Morrissey G. R., Khavari P. A., Immunization via hair follicles by topical application of naked DNA to normal skin Nature Biotechnology 1999 17 9 870 872
23. Gurunathan S., Klinman D. M., Seder R. A., DNA vaccines: immunology, application, and optimization Annual Review of Immunology 2000 18 927 974
24. Kutzler M. A., Weiner D. B., DNA vaccines: ready for prime time? Nature Reviews Genetics 2008 9 10 776 788
25. Akbari O., Panjwani N., Garcia S., Tascon R., Lowrie D., Stockinger B., DNA vaccination: transfection and activation of dendritic cells as key events for immunity Journal of Experimental Medicine 1999 189 1 169 177
26. Porgador A., Irvine K. R., Iwasaki A., Barber B. H., Restifo N. P., Germain R. N., Predominant role for directly transfected dendritic cells in antigen presentation to CD 8 + T cells after gene gun immunization Journal of Experimental Medicine 1998 188 6 1075 1082
27. Pertmer T. M., Roberts T. R., Haynes J. R., Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery Journal of Virology 1996 70 9 6119 6125
28. Yoshida A., Nagata T., Uchijima M., Higashi T., Koide Y., Advantage of gene gun-mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses Vaccine 2000 18 17 1725 1729
29. Feltquate D. M., Heaney S., Webster R. G., Robinson H. L., Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization Journal of Immunology 1997 158 5 2278 2284
30. Uchijima M., Yoshida A., Nagata T., Koide Y., Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium Journal of Immunology 1998 161 10 5594 5599
31. Nagata T., Uchijima M., Yoshida A., Kawashima M., Koide Y., Codon optimization effect on translational efficiency of DNA vaccine in mammalian cells: analysis of plasmid DNA encoding a CTL epitope derived from microorganisms Biochemical and Biophysical Research Communications 1999 261 2 445 451
32. Cho J. H., Youn J. W., Sung Y. C., Cross-priming as a predominant mechanism for inducing CD 8 + T cell responses in gene gun DNA immunization Journal of Immunology 2001 167 10 5549 5557
33. Birzofsky J. A., Epitope selection and design of synthetic vaccines Annals of the New York Academy of Sciences 1993 690 256 264
34. Wolkers M. C., Toebes M., Okabe M., Haanen J. B. A. G., Schumacher T. N. M., Optimizing the efficacy of epitope-directed DNA vaccination Journal of Immunology 2002 168 10 4998 5004
35. Maecker H. T., Umetsu D. T., DeKruyff R. H., Levy S., Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC Journal of Immunology 1998 161 12 6532 6536
36. Yoshida A., Nagata T., Uchijima M., Koide Y., Protective CTL response is induced in the absence of CD 4 + T cells and IFN- by gene gun DNA vaccination with a minigene encoding a CTL epitope of Listeria monocytogenes Vaccine 2001 19 4297 4306
37. Whitton J. L., Sheng N., Oldstone M. B. A., Mckee T. A., A string-of-beads vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge Journal of Virology 1993 67 1 348 352
38. Thomson S. A., Sherritt M. A., Medveczky J., Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination The Journal of Immunology 1998 160 1717 1723
39. Yamada T., Uchiyama H., Nagata T., Protective cytotoxic T lymphocyte responses induced by DNA immunization against immunodominant and subdominant epitopes of Listeria monocytogenes are noncompetitive Infection and Immunity 2001 69 5 3427 3430
40. Del Val M., Schlicht H. J., Ruppert T., Reddehase M. J., Koszinowski U. H., Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein Cell 1991 66 6 1145 1153
41. Velders M. P., Weijzen S., Eiben G. L., Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine The Journal of Immunology 2001 166 5366 5373
42. Ishioka G. Y., Fikes J., Hermanson G., Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes The Journal of Immunology 1999 162 3915 3925
43. Aoshi T., Suzuki M., Uchijima M., Nagata T., Koide Y., Expression mapping using a retroviral vector for CD 8 + T cell epitopes: definition of a Mycobacterium tuberculosis peptide presented by H2- D d Journal of Immunological Methods 2005 298 1-2 21 34
44. Aoshi T., Nagata T., Suzuki M., Identification of an HLA-A 0201 -restricted T-cell epitope on the MPT51 protein, a major secreted protein derived from Mycobacterium tuberculosis, by MPT51 overlapping peptide screening Infection and Immunity 2008 76 4 1565 1571
45. Suzuki M., Aoshi T., Nagata T., Koide Y., Identification of murine H2- D d-and H2- A b -restricted T-cell epitopes on a novel protective antigen, MPT51, of Mycobacterium tuberculosis Infection and Immunity 2004 72 7 3829 3837
46. Parker K. C., Bednarek M. A., Coligan J. E., Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains Journal of Immunology 1994 152 1 163 175
47. Rammensee H.-G., Bachmann J., Emmerich N. P. N., Bachor O. A., Stevanovi S., SYFPEITHI: database for MHC ligands and peptide motifs Immunogenetics 1999 50 3-4 213 219
48. Dietrich G., Gentschev I., Hess J., Ulmer J. B., Kaufmann S. H. E., Goebel W., Delivery of DNA vaccines by attenuated intracellular bacteria Immunology Today 1999 20 6 251 253
49. Sizemore D. R., Branstrom A. A., Sadoff J. C., Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization Science 1995 270 299 302
50. Sizemore D. R., Branstrom A. A., Sadoff J. C., Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization Vaccine 1997 15 8 804 807
51. Fennelly G. J., Khan S. A., Abadi M. A., Fabian Wild T., Bloom B. R., Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector Journal of Immunology 1999 162 3 1603 1610
52. Hoiseth S. K., Stocker B. A. D., Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines Nature 1981 291 5812 238 239
53. Darji A., Guzmn C. A., Gerstel B., Oral somatic transgene vaccination using attenuated S. typhimurium Cell 1997 91 6 765 775
54. Albert M. L., Sauter B., Bhardwaj N., Dendritic cells acquire antigen from apoptotic cells and induce class I- restricted CTLS Nature 1998 392 6671 86 89
55. Darji A., zur Lage S., Garbe A. I., Chakraborty T., Weiss S., Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier FEMS Immunology and Medical Mirobiology 2000 27 341 349
56. Grillot-Courvalin C., Goussard S., Courvalin P., Wild-type intracellular bacteria deliver DNA into mammalian cells Cellular Microbiology 2002 4 3 177 186
57. Hense M., Domann E., Krusch S., Eukaryotic expression plasmid transfer from the intracellular bacterium Listeria monocytogenes to host cells Cellular Microbiology 2001 3 9 599 609
58. Dietrich G., Bubert A., Gentischev I., Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes Nature Biotechnology 1998 16 181 185
59. Hauf N., Goebel W., Fiedler F., Sokolovic Z., Kuhn M., Listeria monocytogenes infectoin of P388D 1 macrophages results in a biphasic NF- B (RelA/p50) activation induced by lipoteichoic acid and bacterial phospholipases and mediated by I B and I B degradation Proceedings of the National Academy of Sciences of the United States of America 1997 94 17 9394 9399
60. Miki K., Nagata T., Tanaka T., Induction of protective cellular immunity against Mycobacterium tuberculosis by recombinant attenuated self-destructing Listeria monocytogenes strains harboring eukaryotic expression plasmids for antigen 85 complex and MPB/MPT51 Infection and Immunity 2004 72 4 2014 2021
61. Spreng S., Dietrich G., Niewiesk S., ter Meulen V., Gentschev I., Goebel W., Novel bacterial systems for the delivery of recombinant protein of DNA FEMS Immunology and Medical Microbiology 2000 27 299 304
62. Pilgrim S., Stritzker J., Schoen C., Bactofection of mammalian cells by Listeria monocytogenes: improvement and mechanism of DNA delivery Gene Therapy 2003 10 24 2036 2045
63. Banchereau J., Steinman R. M., Dendritic cells and the control of immunity Nature 1998 392 245 252
64. McShane H., Behboudi S., Goonetilleke N., Brookes R., Hill A. V. S., Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD 8 +-and CD 4 + -T-cell epitopes from antigen 85A Infection and Immunity 2002 70 3 1623 1626
65. Badovinac V. P., Messingham K. A. N., Jabbari A., Haring J. S., Harty J. T., Accelerated CD 8 + T-cell memory and prime-boost response after dendritic-cell vaccination Nature Medicine 2005 11 7 748 756
66. Nakamura Y., Suda T., Nagata T., Induction of protective immunity to Listeria monocytogenes with dendritic cells retrovirally transduced with a cytotoxic T lymphocyte epitope minigene Infection and Immunity 2003 71 4 1748 1754
67. Nakano H., Nagata T., Suda T., Immunization with dendritic cells retrovirally transduced with mycobacterial antigen 85A gene elicits the specific cellular immunity including cytotoxic T-lymphocyte activity specific to an epitope on antigen 85A Vaccine 2006 24 12 2110 2119
68. Wang J., Thorson L., Stokes R. W., Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis Journal of Immunology 2004 173 10 6357 6365
69. Brossart P., Goldrath A. W., Butz E. A., Martin S., Bevan M. J., Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL Journal of Immunology 1997 158 7 3270 3276
70. Nanda A., Lynch D. M., Goudsmit J., Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and Rhesus monkeys Journal of Virology 2005 79 22 14161 14168
71. Song E. S., Lee V., Surh C. D., Antigen presentation in retroviral vector-mediated gene transfer in vivo Proceedings of the National Academy of Sciences of the United States of America 1997 94 5 1943 1948
72. Naldini L., Blmer U., Gallay P., In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector Science 1996 272 5259 263 267
73. Yang L., Yang H., Rideout K., Engineered lentivector targeting of dendritic cells for in vivo immunization Nature Biotechnology 2008 26 3 326 334
74. Medina M. F., Kobinger G. P., Rux J., Lentifiral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung Molecular Therapy 2003 8 5 777 789
75. Hashimoto D., Nagata T., Uchijima M., Intratracheal administration of third-generation lentivirus vector encoding MPT51 from Mycobacterium tuberculosis induces specific CD 8 + T-cell responses in the lung Vaccine 2008 26 40 5095 5100
76. Esslinger C., Chapatte L., Finke D., Miconnet I., Guillaume P., MacDonald H. R., In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD 8 + T cell responses Journal of Clinical Investigation 2003 111 11 1673 1681
77. Li S., Rodrigues M., Rodriguez D., Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD 8 + T-cell-mediated protective immunity against malaria Proceedings of the National Academy of Sciences of the United States of America 1993 90 11 5214 5218
78. Ramshaw I. A., Ramsay A. J., The prime-boost strategy: exciting prospects for improved vaccination Immunology Today 2000 21 4 163 165
79. Eo S. K., Gierynska M., Kamar A. A., Rouse B. T., Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules Journal of Immunology 2001 166 9 5473 5479
80. McShane H., Hill A., Prime-boost immunisation strategies for tuberculosis Microbes and Infection 2005 7 5-6 962 967
81. Tanghe A., D'Souza S., Rosseels V., Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85by protein boosting Infection and Immunity 2001 69 5 3041 3047
82. Wang Q.-M., Sun S.-H., Hu Z.-L., Yin M., Xiao C.-J., Zhang J.-C., Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting Vaccine 2004 22 27-28 3622 3627
83. McShane H., Brookes R., Gilbert S. C., Hill A. V. S., Enhanced immunogenicity of CD 4 + T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis Infection and Immunity 2001 69 2 681 686
84. Feng C. G., Palendira U., Demangel C., Spratt J. M., Malin A. S., Britton W. J., Priming by DNA immunization augments protective efficacy of Mycobacterium bovis bacille Calmette-Gurin against tuberculosis Infection and Immunity 2001 69 6 4174 4176
85. Skinner M. A., Ramsay A. J., Buchan G. S., A DNA prime-live vaccine boost strategy in mice can augment IFN- responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis Immunology 2003 108 4 548 555
86. Romano M., D'Souza S., Adnet P.-Y., Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv Vaccine 2006 24 16 3353 3364
87. Goonetilleke N. P., McShane H., Hannan C. M., Anderson R. J., Brookes R. H., Hill A. V. S., Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Gurin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara Journal of Immunology 2003 171 3 1602 1609
88. McShane H., Pathan A. A., Sander C. R., Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans Nature Medicine 2004 10 11 1240 1244
89. Santosuosso M., McCormick S., Zhang X., Zganiacz A., Xing Z., Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis Infection and Immunity 2006 74 8 4634 4643
90. Tchilian E. Z., Desel C., Forbes E. K., Immunogenicity and protective efficacy of prime-boost regimens with recombinant ureC hly + Mycobacterium bovis BCG and modified vaccinia virus Ankara expressing M. tuberculosis antigen 85A against murine tuberculosis Infection and Immunity 2009 77 2 622 631